Denali Therapeutics Inc. DNLI Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$128.45M+0.1% | -$128.55M-1.3% | -$126.9M-2.2% | -$124.12M+6.7% | -$132.97M-15.9% | ||
| $2.85M-0.7% | $2.87M-2.7% | $2.95M-3.2% | $3.05M+31.0% | $2.33M+25.5% | ||
| $23.09M-3.6% | $23.95M-4.7% | $25.14M-1.0% | $25.39M+0.9% | $25.16M+0.3% | ||
| -$131.2M-33.2% | -$98.54M+8.2% | -$107.3M-42.5% | -$75.3M+42.7% | -$131.47M-57.0% | ||
| $2.47M+61.8% | $1.52M— | —— | $4.28M-15.8% | $5.08M-0.3% | ||
| $94.46M+355% | $20.77M-64.1% | $57.83M-63.4% | $157.94M+742% | $18.75M— | ||
| $219.04M+14.0% | $192.13M+24,796% | -$778K-148% | $1.62M+143% | -$3.76M— | ||
| $182.3M+59.4% | $114.36M+328% | -$50.24M-160% | $84.26M+172% | -$116.48M-238% | ||
| -$133.67M-33.6% | -$100.06M+5.5% | -$105.92M-33.1% | -$79.58M+41.7% | -$136.55M-53.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Denali Therapeutics Inc.'s cash flow data come from?
- Every line is extracted from Denali Therapeutics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.